Disclosure Panels Details Page
Hodgkin Lymphoma Panel - Disclosures as of 04/24/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Ranjana Advani MD | ADC Therapeutics Autolus BeiGene Conjupro Cyteir Daiichi- Sankyo Co. Genentech/Roche Gilead Sciences, Inc. Merck & Co., Inc. MorphoSys AG Regeneron Pharmaceuticals, Inc. Roche |
ADC Therapeutics Autolus BeiGene Genentech, Inc. Roche |
None | None | 01/11/2024 |
| Richard Ambinder PhD,MD | National Cancer Institute | legal | None | None | 12/21/2023 |
| Philippe Armand PhD,MD | Adaptive ADC Therapeutics AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Genentech, Inc. IGM Kite Pharma Merck & Co., Inc. |
ATB Bio Bristol Myers Squibb Enterome Foresight GenMab Merck & Co., Inc. Regeneron Pharmactcls |
None | None | 01/28/2024 |
| Celeste Bello MSPH,MD | None | Monsanto Corporation | None | None | 01/03/2024 |
| Cecil Benitez PhD,MD | None | None | None | None | 12/11/2023 |
| Marian Birkeland PhD | None | None | None | None | 04/02/2024 |
| Nicole Blankenhorn | None | None | None | None | 03/04/2024 |
| Weina Chen PhD,MD | None | None | None | None | 03/27/2024 |
| Sheen Cherian MD | None | None | None | None | 11/10/2023 |
| Bouthaina Dabaja MD | None | None | None | None | 01/03/2024 |
| Megan Daly MD | EMD Serono Genentech, Inc. Merck & Co., Inc. |
AstraZeneca Pharmaceuticals LP Novocure Prelude Corporation |
Curio DAVA |
None | 04/18/2024 |
| Sarah DeVincenzo PharmD,BCPS | None | None | None | None | 02/26/2024 |
| Zachary Frosch MD,MSHP | AbbVie, Inc. Acerta Pharma Amgen Inc. Antigenics Inc. AstraZeneca Pharmaceuticals LP Genmab Roche Laboratories, Inc. sanofi-aventis U.S. |
None | None | None | 03/21/2024 |
| Leo Gordon MD | Janssen Pharmaceutica Products, LP Zylem Biosciences |
Ono Pharmaceuticals | None | None | 01/08/2024 |
| Kristina Gregory MSN,RN | None | None | None | None | 01/10/2024 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | 02/02/2024 |
| Neil Hansen MD | None | None | None | None | 11/03/2023 |
| Alex Herrera MD | None | AbbVie, Inc. ADC Therapeutics Adicet Bio Allogene Therapeutics AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Caribou Genentech, Inc. Genmab Karyopharm Therapeutics Merck & Co., Inc. Pfizer Inc. Regeneron Pharmaceuticals, Inc. Seattle Genetics Takeda Pharmaceuticals North America, Inc. Tubulis |
None | None | 03/13/2024 |
| Erin Hesler | None | None | None | None | 12/22/2023 |
| Ephraim Hochberg MD | Abiomed Medtronic, Inc. |
Leuko | None | None | 04/24/2024 |
| Richard Hoppe MD | None | Oregon Health Sciences University Telan Meltz Wallace + Eide, Maitland FL |
None | None | 03/04/2024 |
| Iris Isufi MD | Janssen Pharmaceutica Products, LP | Bristol Myers Squibb Janssen Pharmaceutica Products, LP |
Gilead Sciences, Inc. | None | 04/07/2024 |
| Patrick Johnston MD,PhD | None | None | None | None | 03/28/2024 |
| Madeline Joyce OCN,RN,BSN | None | None | None | None | 03/28/2024 |
| Kara Kelly MD | Bristol Myers Squibb Merck & Co., Inc. |
Merck & Co., Inc. | None | None | 10/27/2023 |
| Christopher Kelsey MD | Galera Therapeutics | Colgate-Palmolive Johnson & Johnson |
None | None | 02/27/2024 |
| Vaishalee Kenkre MD | None | None | None | None | 03/26/2024 |
| Justin Kline MD | None | AbbVie, Inc. ADC Therapeutics BeiGene Curio Science Gilead Sciences, Inc. SeaGen |
Targeted Oncology | None | 04/09/2024 |
| Ryan Lynch MD | Bayer HealthCare Cyteir Genentech, Inc. Incyte Corporation Merck & Co., Inc. RAPT TG Therapeutics |
AbbVie, Inc. Janssen Pharmaceutica Products, LP |
None | None | 01/21/2024 |
| Kami Maddocks MD | None | AbbVie, Inc. Acerta Pharma AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Eli Lilly and Company Genentech, Inc. Janssen Pharmaceutica Products, LP Kite Pharma Pharmacyclics |
None | None | 11/26/2023 |
| Jonathan McConathy MD,PhD | Blue Earth Diagnostics Clovis Oncology Cytosite Fusion Pharmaceuticals Navidea Novartis Pharmaceuticals Corporation |
Blue Earth Diagnostics Eli Lilly and Company General Electric ImaginAb Novartis Pharmaceuticals Corporation Telix |
None | None | 11/10/2023 |
| Monica Mead MD | None | None | None | None | 02/21/2024 |
| Sarah Montgomery | None | None | None | None | 01/26/2024 |
| David Morgan MD | None | None | None | None | 04/19/2024 |
| Carolyn Mulroney MD | Angiocrine Aptose CALIBR, Scripps research institute Novartis Pharmaceuticals Corporation |
None | None | None | 11/03/2023 |
| Alex Niu MD | None | None | None | None | 01/26/2024 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 03/13/2024 |
| Rachel Rabinovitch MD | None | None | None | None | 03/07/2024 |
| Dahlia Sano MBChB | None | None | None | None | 04/05/2024 |
| Harsh Shah DO | Acerta Pharma AstraZeneca Pharmaceuticals LP BeiGene SeaGen |
SeaGen | None | None | 12/07/2023 |
| Michael Spinner MD | None | None | None | None | 03/15/2024 |
| Katie Stehman PA-C,MMS | None | None | None | None | 03/11/2024 |
| Jakub Svoboda MD | Adaptive AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Incyte Corporation Kite Pharma Merck & Co., Inc. Pharmacyclics TG Therapeutics |
Adaptive AstraZeneca Pharmaceuticals LP ATARA CRISPR Therapeutics |
None | None | 04/09/2024 |
| Erin Vidic | None | None | None | None | 12/15/2023 |
| Jane Winter MD | Epizyme Merck & Co., Inc. Novartis Pharmaceuticals Corporation Takeda Pharmaceuticals North America, Inc. |
Bristol Myers Squibb Curis-Spouse CVS Caremark -Spouse Genentech, Inc. Ipsen- Spouse Novartis- Spouse |
Merck & Co., Inc. | None | 02/18/2024 |
| Joachim Yahalom MD | None | None | None | None | 11/08/2023 |
| Joanna Yang MD,MPH | None | None | None | None | 11/03/2023 |